All-trans-retinoic acid inhibits growth of head and neck cancer stem cells by suppression of Wnt/β-catenin pathway

European Journal of Cancer

Volumn 48, Issue 17, 2012, Pages 3310-3318

  Lim, Young Chang ^a   Kang, Hyun Jung ^a   Kim, Young Sook ^a   Choi, Eun Chang ^b  

^a Konkuk University School of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

All trans retinoic acid; Differentiation; Head and neck cancer; Neoplastic stem cells; Therapy

Indexed keywords

BETA CATENIN; CISPLATIN; HERMES ANTIGEN; NESTIN; OCTAMER TRANSCRIPTION FACTOR 4; RETINOIC ACID; TRANSCRIPTION FACTOR SOX2;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER STEM CELL; CELL ASSAY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; CHEMOSENSITIZATION; COLORIMETRY; CONTROLLED STUDY; CULTURE MEDIUM; DOWN REGULATION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; WNT SIGNALING PATHWAY;

ANIMALS; ANTINEOPLASTIC AGENTS; BETA CATENIN; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; CISPLATIN; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MICE; MICE, INBRED BALB C; NEOPLASTIC STEM CELLS; TRETINOIN; WNT SIGNALING PATHWAY;

EID: 84868203536     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.04.013     Document Type: Article

References (28)

1. F. Kamangar, G.M. Dores, and W.F. Anderson Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world J Clin Oncol 24 2006 2137 2150
2. C.R. Leemans, B.J. Braakhuis, and R.H. Brakenhoff The molecular biology of head and neck cancer Nat Rev Cancer 11 2011 9 22
3. S.K. Singh, I.D. Clarke, and M. Terasaki Identification of a cancer stem cell in human brain tumors Cancer Res 63 2003 5821 5828
4. S. Zhang, C. Balch, and M.W. Chan Identification and characterization of ovarian cancer-initiating cells from primary human tumors Cancer Res 68 2008 4311 4320
5. C.F. Kim, E.L. Jackson, and A.E. Woolfenden Identification of bronchioalveolar stem cells in normal lung and lung cancer Cell 121 2005 823 835
6. A.T. Collins, P.A. Berry, C. Hyde, M.J. Stower, and N.J. Maitland Prospective identification of tumorigenic prostate cancer stem cells Cancer Res 65 2005 10946 10951
7. P. Dalerba, S.J. Dylla, and I.K. Park Phenotypic characterization of human colorectal cancer stem cells Proc Natl Acad Sci U S A 104 2007 10158 10163
8. M. Al-Hajj, M.S. Wicha, A. Benito-Hernandez, S.J. Morrison, and M.F. Clarke Prospective identification of tumorigenic breast cancer cells Proc Natl Acad Sci U S A 100 2003 3983 3988
9. C.T. Jordan, M.L. Guzman, and M. Noble Cancer stem cells N Engl J Med 355 2006 1253 1261
10. M. Dean, T. Fojo, and S. Bates Tumour stem cells and drug resistance Nat Rev Cancer 5 2005 275 284
11. M. Ying, S. Wang, and Y. Sang Regulation of glioblastoma stem cells by retinoic acid: role for notch pathway inhibition Oncogene 30 2011 3454 3467
12. Y.C. Lim, S.Y. Oh, Y.Y. Cha, S.H. Kim, X. Jin, and H. Kim Cancer stem cell traits in squamospheres derived from primary head and neck squamous cell carcinomas Oral oncol 47 2011 83 91
13. B. Campos, F. Wan, and M. Farhadi Differentiation therapy exerts antitumor effects on stem-like glioma cells Clin Cancer Res 16 2010 2715 2728
14. M. Katoh, and M. Katoh Wnt signaling pathway and stem cell signaling network Clin Cancer Res 13 2007 40424045
15. S. Iwai, A. Yonekawa, and C. Harada Involvement of the Wnt-β-catenin pathway in invasion and migration of oral squamous carcinoma cells Int J Oncol 37 2010 1095 1103
16. J.G. Jurcic, S.L. Soignet, and A.P. Maslak Diagnosis and treatment of acute promyelocytic leukemia Curr Oncol Rep 9 2007 337 344
17. M.E. Prince, R. Sivanandan, and A. Kaczorowski Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma Proc Natl Acad Sci U S A 104 2007 973 978
18. N. Takebe, P.J. Harris, R.Q. Warren, and S.P. Ivy Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways Nat Rev Clin Oncol 8 2011 97 106
19. C.S. Niu, M.W. Li, and Y.F. Ni Effect of all-trans retinoic acid on the proliferation and differentiation of brain tumor stem J Exp Clin Cancer Res 29 2010 113
20. Paroni G, Fratelli M, Gardini G, et al. Synergistic antitumor activity of lapatinib and retinoids on a novel subtype of breast cancer with coamplification of ERBB2 and RARA. Oncogene, in press.
21. M. Gianni', A. Boldetti, and V. Guarnaccia Inhibition of the peptidyl-prolyl-isomerase Pin1 enhances the responses of acute myeloid leukemia cells to retinoic acid via stabilization of RARalpha and PML-RARalpha Cancer Res 69 2009 1016 1026
22. E. Garattini, M. Gianni, and M. Terao Retinoids as differentiating agents in oncology: a network of interactions with intracellular pathways as the basis for rational therapeutic combinations Curr Pharm Des 13 2007 1375 1400
23. H. Clevers Wnt/beta-catenin signaling in development and disease Cell 127 2006 469 480
24. V. Easwaran, M. Pishvaian, Salimuddin, and S. Byers Cross-regulation of beta-catenin-LEF/TCF and retinoid signaling pathways Curr Biol 9 1999 1415 1418
25. R. Yasuhara, T. Yuasa, and J.A. Williams Wnt/beta-catenin and retinoic acid receptor signaling pathways interact to regulate chondrocyte function and matrix turnover J Biol Chem 285 2010 317 327
26. W.K. Hong, J. Endicott, and L.M. Itri 13-cis-retinoic acid in the treatment of oral leukoplakia N Engl J Med 315 1986 1501 1505
27. W.K. Hong, S.M. Lippman, and L.M. Itri Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck N Engl J Med 323 1990 795 801
28. W. Smith, and N. Saba Retinoids as chemoprevention for head and neck cancer: where do we go from here? Crit Rev Oncol Hematol 55 2005 143 152